| UNITED STATES |
| SECURITIES AND EXCHANGE COMMISSION |
| Washington, D.C. 20549 |
| |
| FORM 6-K |
| |
| REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 |
| UNDER THE SECURITIES EXCHANGE ACT OF 1934 |
| |
| For the month of July 2025 |
| |
| Commission File Number: 001-40086 |
| |
| PORTAGE BIOTECH INC. |
| (Translation of registrant's name into English) |
| |
| Clarence Thomas Building, P.O. Box 4649, Road Town, Tortola, British Virgin Islands, VG1110 |
| (Address of principal executive office) |
| Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. |
| |
| Form 20-F [ X ] |
Form 40-F [ ] |
INCORPORATION BY REFERENCE
This report on Form 6-K (including any exhibits attached hereto) shall
be deemed to be incorporated by reference into the registration statement on Form S-8 (File No. 333-275842) and Form F-3, as amended (File
No. 333-286961) of Portage Biotech Inc. (including any prospectuses forming a part of such registration statement) and to be a part thereof
from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.
EXHIBITS
| Exhibit No. |
Description |
| |
|
| 99.1* |
Press Release dated July 25, 2025 |
| _______ |
|
| * Filed herewith |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: July 25, 2025
PORTAGE BIOTECH INC.
| By: |
/s/ Andrea Park |
|
| |
Andrea Park |
|
| |
Chief Financial Officer |
|
| |
|
|
